Lawyers for litigation

Novartis AG v Pharmacor PL (No 3) [2024] FCA 1307

Novartis AG v Pharmacor PL (No 3) [2024] FCA 1307

PATENTS – infringement – standard patent for a pharmaceutical composition containing certain active pharmaceutical ingredients (APIs) – claim construction – whether claim covers a pharmaceutical composition where the API is in the form of a complex in which the ions are associated by non-covalent bonds

PATENTS – identity of the person skilled in the art – where the person skilled in the art is understood as a “team” – discussion of the characteristics of the person skilled in the art

PATENTS – validity – lack of inventive step – availability of prior art information – whether person skilled in the art could be reasonably expected to have ascertained and regarded as relevant certain prior art publications

PATENTS – validity – lack of inventive step – discussion of the reformulated “Cripps question” – whether obviousness established on the evidence

PATENTS – extension of patent term – whether extension validly granted – whether rectification of the Register of Patents should be ordered

Related cases

  • Oxford Nanopore Technologies Plc v MGI Aust PL [2025] FCA 572

    PRACTICE AND PROCEUDRE – application to set aside notice to produce served on prospective applicant – where prospective respondent’s nanopore sequencing devices may fall within the scope of one or more claims of patents owned by the prospective applicant – where category 1 seeks documents recording or evidencing prospective applicant’s belief that it may have…

  • MSA 4X4 Accessories PL v Clearview Towing Mirrors PL (Discovery) [2025] FCA 375

    PATENTS – discovery – significant claim for damages following liability judgment – discovery application successful with modifications made to categories of discovery sought Related cases about Patent disputes Original article available at: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2025/2025fca0375For more information, see the original judgement.

  • Novartis AG v Pharmacor PL [2025] FCAFC 33

    PATENTS – infringement – standard patent for a pharmaceutical composition containing certain active pharmaceutical ingredients – claim construction – whether primary judge erred in construction of claim as not including a pharmaceutical composition where the active pharmaceutical ingredient is in the form of a complex in which the ions are associated by non-covalent bonds –…

Original article available at: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2024/2024fca1307

For more information, see the original judgement.

Send this to a friend